Retinopathy and Systemic Disease Morbidity in Severe COVID-19.
Saved in:
| Title: | Retinopathy and Systemic Disease Morbidity in Severe COVID-19. |
|---|---|
| Authors: | Shantha JG; Emory Eye Center, Emory University School of Medicine, Atlanta, GA, USA., Auld SC; Department of Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Anthony C; Emory Eye Center, Emory University School of Medicine, Atlanta, GA, USA., Ward L; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA., Adelman MW; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA., Maier CL; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA., Price KW; Emory Eye Center, Emory University School of Medicine, Atlanta, GA, USA., Jacob JT; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA., Fashina T; Emory Eye Center, Emory University School of Medicine, Atlanta, GA, USA., Randleman C; Emory Eye Center, Emory University School of Medicine, Atlanta, GA, USA., Xu LT; Emory Eye Center, Emory University School of Medicine, Atlanta, GA, USA., Barnett J; Emory Eye Center, Emory University School of Medicine, Atlanta, GA, USA., Sadan O; Department of Neurology and Neurosurgery, Division of Neurocritical Care, Emory University School of Medicine, Atlanta, GA, USA., Kandiah PA; Department of Neurology and Neurosurgery, Division of Neurocritical Care, Emory University School of Medicine, Atlanta, GA, USA., Varkey JB; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA., Kraft CS; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA., Rouphael N; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA., Linderman S; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA., Ahmed R; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA., Drews-Botsch C; Department of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, VA, USA., Waggoner JJ; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA., Weinmann M; Department of Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Emory University School of Medicine, Atlanta, GA, USA., Murphy DJ; Department of Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Emory University School of Medicine, Atlanta, GA, USA., Yeh S; Emory Eye Center, Emory University School of Medicine, Atlanta, GA, USA.; Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA. |
| Corporate Authors: | Emory COVID-19 Quality and Clinical Research Collaborative |
| Source: | Ocular immunology and inflammation [Ocul Immunol Inflamm] 2021 May 19; Vol. 29 (4), pp. 743-750. Date of Electronic Publication: 2021 Aug 31. |
| Publication Type: | Journal Article; Multicenter Study; Observational Study |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-5078 (Electronic) Linking ISSN: 09273948 NLM ISO Abbreviation: Ocul Immunol Inflamm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1744-5078 |
|---|---|
| DOI: | 10.1080/09273948.2021.1952278 |
